4
Changes in Ownership
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-012539
EVP, Chief R&D Officer sold 6,326 shares at $60.38 ($381,937)
From the SEC's structured data for this filing
Trades in this filing
Friberg Gregory R · EVP, Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-26 | Sale : show line 1 in the form | −6,326 | $60.38 | $381,937 | 37,578 | D |
| Open-market sales · 6,326 sh · avg $60.38 · $381,937 | ||||||
Loading xslF345X05/wk-form4_1772156343.xml…